LZLele Zhang

Lele Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lele Zhang has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Mingjie Ding

    Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    3 shared publications
  • Wenzhi Guo

    Department of Hepatobiliary and Pancreatic Surgery, Henan Key Laboratory of Digestive Organ Transplantation, Zhengzhou Key Laboratory of Hepatobiliary & Pancreatic Diseases and Organ Transplantation, Open and Key Laboratory of Hepatobiliary & Pancreatic Surgery and Digestive, The First Affiliated Hospital of Zhengzhou University, Organ Transplantation at Henan Universities, Zhengzhou City, People’s Republic of China

    3 shared publications
  • Guohua You

    Department of Surgical Intensive Care Unit, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    2 shared publications
  • Ying Zhu

    Department of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

    2 shared publications
  • Zhiping Yan

    Department of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

    2 shared publications
  • Changhong Li

    Department of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

    1 shared publication

Latest Publications

  • Open Access

    Protective effect of Caftaric Acid against hepatic cold ischemia/reperfusion injury in the liver

    by Ying Zhu, Hao Li, Minghao Li, Wenzheng Ruan, Mingjie Ding, Guohua You, Lele Zhang, Wenzhi Guo

    Hepatic cold ischemia/reperfusion (I/R) injury persists during the perioperative period of liver transplantation (LT), exerting a profound impact on graft survival and being closely associated with the occurrence of early allograft dysfunction (EAD). Currently, preventive strategies against cold I/R injury remain limited. This study aimed to investigate the protective effects and underlying molecular mechanisms of caftaric acid (CA), a metabolite specifically elevated in cold-adapted hibernating animals, against hepatic cold I/R injury. The results demonstrated that CA significantly reduced the area of hepatic necrosis, attenuated liver injury, inhibited hepatocyte apoptosis, and promoted the restoration of redox homeostasis. RNA-seq analysis suggested that the MAPK pathway, particularly the activation of JNK1, plays a pivotal role in the process of cold I/R injury. Through integrated experiments including drug-target screening, molecular docking, and surface plasmon resonance (SPR), this study confirmed that CA directly binds to and interacts with JNK1, thereby regulating its phosphorylation function. Further investigations revealed that CA modulates the MAPK cascade (JNK1/FOS) to alleviate oxidative stress, mitochondrial dysfunction, and cellular apoptosis during hepatic cold I/R injury. In summary, these findings suggest that CA holds promise as a potential therapeutic strategy for ameliorating hepatic cold I/R injury, with significant clinical implications.

  • In‐Depth Optimization and Systematic Evaluation of a Recombinant AAV ‐Based Hepatic‐Targeted Gene Knockdown Murine Model

    by Ying Zhu, Guohua You, Yong Jiang, Keyu Yin, Rui Wang, Changhong Li, Xiaodan Zhang, Zhiping Yan, Mingjie Ding, Wenzhi Guo, et al.

    Precise gene‐edited animal models are essential for preclinical liver research but are typically time‐consuming and costly. Here, a liver‐specific knockdown mouse model was developed based on a recombinant AAV (rAAV) tool, which is rapid and economical, with optimized delivery methods and systematically evaluated knockdown efficiency. Hepatic ischemia/reperfusion (IR) injury‐related genes ( Btg2 , Flrt3 , Klf4 ) were screened through GEO data mining. To knock down these genes, rAAV vectors featuring a liver‐specific promoter TBG669, Firefly luciferase (Fluc) for real‐time tracking, and miR30‐based regulatory elements were engineered. Delivery protocols were optimized through comparative analysis of reporting systems (GFP vs. Fluc), administration routes (tail vein vs. dorsal penile vein), and doses (half [2.5 × 10 11 GC] vs. full dose [5.0 × 10 11 GC]). Safety and knockdown efficiency were systematically assessed using histopathology, serum biochemistry, qRT‐PCR, and western blot analysis both in bulk liver tissue and single‐cell subsets. The optimized rAAV system achieved 100% hepatic infection rates with minimal off‐target expression. Dorsal penile vein injection simplified delivery without compromising efficacy. Full‐dose administration produced stronger bioluminescence by Week 4, with no adverse effects on organ function or histology. For knockdown efficiencies, Btg2 and Flrt3 mRNA and protein levels were reduced by > 50%, whereas Klf4 exhibited moderate suppression in bulk liver tissue. In single‐cell subsets, the three genes were all effectively knocked down in Kupffer cells, followed by hepatocytes and LSECs. A time‐ and cost‐efficient rAAV‐based hepatic gene knockdown murine model was established, enabling precise investigation of liver disease mechanisms and therapeutic development.


  • Open Access

    A simplified and reproducible ex vivo model of cold and ischemia-reperfusion injury

    by Lele Zhang, Mingjie Ding, Ying Zhu, Zhiping Yan, Wenzhi Guo

    Both cold stress and ischemia-reperfusion injury significantly contribute to poor prognosis after liver transplantation (LT). However, limited animal models incorporating both stimuli hinder the advancement of transplant-related research. Here, a simplified and reproducible isolated perfused liver model is established to simulate the stresses experienced by livers maximally during transplantation. We provide a detailed protocol for a straightforward technique that requires 20–30 min for harvesting, 24–48 h for static cold storage (SCS), and 2 h for normothermic machine perfusion (NMP) to induce LT-like stresses in the liver. Hepatic injury from SCS and NMP (LT-like stresses) is evaluated using three types of parameters. The pH values and hepatic enzyme levels of cold preservation solutions and perfusate serve as dynamic indicators of hepatic injury. Bile production and portal venous resistance directly reflect liver function, whereas pathological analysis visually illustrates the location and extent of injury. This animal model eliminates the influence of hemodynamic and immune factors, yielding highly reproducible results, and is strongly recommended as a standardized animal model for inducing LT-like stresses.


  • Open Access

    Cross-species metabolomic profiling reveals phosphocholine-mediated liver protection from cold and ischemia/reperfusion

    by Lele Zhang, Liang Chen, Yong Jiang, Guanghui Jin, Jinghong Yang, Haobin Sun, Jinliang Liang, Guo Lv, Qing Yang, Shuhong Yi, et al.


  • Open Access

    The Antitumour Effect of Prunella vulgaris Extract on Thyroid Cancer Cells In Vitro and In Vivo

    by Fangqin Yu, Lele Zhang, Runsheng Ma, Chenguang Liu, Qingduan Wang, Detao Yin

    Prunella vulgaris, a traditional Chinese medicine, has been used to treat various benign and malignant tumours for centuries in China. In our previous studies, Prunella vulgaris extract (PVE) was shown to promote apoptosis in differentiated thyroid cancer (DTC) cells. However, whether other mechanisms are involved in the antitumour effect of PVE in thyroid cancer (TC) cells remains unclear. The present study aimed to investigate the antiproliferative and antimigratory effects of PVE on TC cell lines both in vitro and in vivo. First, the TPC-1 and SW579 human TC cell lines were screened by MTT assay for their high level of sensitivity to PVE. Then, the results of cell growth curve and colony formation assay and cell cycle analyses, wound healing, and migration assays demonstrated that PVE inhibited the proliferation and migration of TPC-1 and SW579 cells. Moreover, the antitumour effect of PVE was verified in a subcutaneous xenotransplanted tumour model. Next, MKI67, PCNA, CTNNB1, and CDH1 were screened by qRT-PCR for their significantly differential expression levels in xenograft tissue with and without PVE treatment, and expression of MKI67, PCNA, and CDH1 was verified by Western blot. Finally, an integrated bioinformatics analysis containing protein-protein interaction network, KEGG pathway, and GO analysis was conducted to explore more potential antitumour mechanisms of PVE. In summary, PVE could inhibit the proliferation and migration of TC cells both in vitro and in vivo, which may have been achieved by modulation of the expression of MKI67, PCNA, and CDH1. These data suggest that PVE has the potential to be developed into a new anticancer drug for the treatment of TC.